Nov. 22, 2022 – The overall risk of myocarditis after a COVID-19 vaccination remains rare, according to a new study published in the Canadian Medical Association Journal.
At the same time, developing inflammation of the heart muscle appears to be more common in men ages 18-29 who receive the Moderna shot. The researchers recommended the Pfizer shot for this group.
“Although observed rates of myocarditis were higher than expected, the benefits of the vaccine in reducing the severity of COVID-19, hospital admission, and deaths far outweigh the risk of developing myocarditis,” says Naveed Janjua, MBBS, the senior study author and executive director…
